Which of the following would be a concern for a patient who presents prescriptions for both verapamil 100 mg and nifedipine 30 mg?

A drug-disease contraindication occurs when a medication may exacerbate an existing medical condition. In this case, neither verapamil nor nifedipine presents a contraindication for most common conditions they treat, such as hypertension or angina, meaning this option does not apply to the situation described.

A narrow therapeutic index refers to drugs where small changes in dose can lead to adverse effects or therapeutic failure. While some medications do exhibit this characteristic, both verapamil and nifedipine do not typically fall into this category, thus making this option irrelevant to the concern of prescribing both medications together.

Duration of therapy addresses how long a patient should be on a particular medication. While it's an important consideration in medication management, it does not pertain to the concurrent use of verapamil and nifedipine, as both are prescribed for similar conditions and can be taken over varying durations without causing concern regarding their simultaneous use.